Extra Super Avana is a combination pharmaceutical agent designed to address two of the most prevalent male sexual health concerns: erectile dysfunction and premature ejaculation. This medication synergistically combines Avanafil, a potent phosphodiesterase type 5 (PDE5) inhibitor, and Dapoxetine, a selective serotonin reuptake inhibitor (SSPI), to facilitate both robust penile erection and improved ejaculatory control. Its dual-mechanism approach offers a comprehensive treatment solution, supported by clinical evidence demonstrating efficacy in enhancing sexual performance and satisfaction. By targeting distinct physiological pathways, Extra Super Avana provides a reliable and effective option for men seeking to overcome these concurrent challenges.

Features

• Contains Avanafil 100mg and Dapoxetine 60mg per tablet
• Rapid onset of action; Avanafil may begin working in as little as 15 minutes
• High selectivity for PDE5 enzyme, reducing risk of off-target effects
• Dapoxetine is specifically approved for the treatment of premature ejaculation
• Formulated for oral administration with high bioavailability
• Manufactured under strict pharmaceutical quality control standards

Benefits

• Achieves and sustains firmer erections suitable for sexual activity
• Significantly prolongs intravaginal ejaculatory latency time (IELT)
• Enhances overall sexual confidence and relationship satisfaction
• Allows for spontaneous sexual activity due to rapid onset
• Reduces anxiety related to sexual performance through reliable efficacy
• Provides a consolidated treatment approach for dual sexual dysfunctions

Common use

Extra Super Avana is prescribed for adult men experiencing both erectile dysfunction (ED) and premature ejaculation (PE). It is particularly beneficial for patients who have not achieved satisfactory results with single-mechanism treatments. The medication is intended for use prior to anticipated sexual activity, not as a daily regimen. Clinical studies indicate highest efficacy in men with acquired or lifelong PE concurrent with mild to moderate ED. It should be used only when sexual activity is intended, as its effects are contingent upon sexual stimulation.

Dosage and direction

The standard recommended dosage is one tablet taken approximately 30 minutes before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water; it may be taken with or without food, though high-fat meals may delay absorption. Do not exceed one dose within a 24-hour period. The medication requires sexual stimulation to achieve therapeutic effect. Patients should not adjust dosage without medical consultation, as individual response and tolerability may vary based on hepatic function, age, and concomitant medications.

Precautions

Patients should undergo cardiovascular assessment before initiating treatment, as sexual activity carries potential cardiac risk. Those with anatomical penile deformities (e.g., Peyronie’s disease) or conditions predisposing to priapism (e.g., sickle cell anemia) should use with extreme caution. Avoid concurrent consumption of grapefruit or grapefruit juice, which may increase serum concentrations. Orthostatic hypotension may occur, particularly when rising quickly from sitting or lying positions. Patients should not use Extra Super Avana with other ED or PE treatments without medical supervision.

Contraindications

Extra Super Avana is contraindicated in patients taking organic nitrates (e.g., nitroglycerin, isosorbide mononitrate) or nitric oxide donors due to risk of severe hypotension. Additional contraindications include hypersensitivity to Avanafil, Dapoxetine, or any excipients; severe hepatic impairment (Child-Pugh class C); and significant cardiac pathology where sexual activity is inadvisable. Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) or monoamine oxidase inhibitors (MAOIs) is prohibited.

Possible side effects

Common adverse reactions (≥2%) include headache, flushing, nasal congestion, dizziness, nausea, and diarrhea. Less frequently reported effects include dyspepsia, back pain, muscle aches, insomnia, and increased blood pressure. Visual disturbances (e.g., color tinge, blurred vision) and hearing changes have been reported with PDE5 inhibitors. Priapism (prolonged erection >4 hours) requires immediate medical attention to prevent permanent damage. Syncope has been reported in approximately 0.2% of patients in clinical trials.

Drug interaction

Significant interactions occur with nitrates (contraindicated), alpha-blockers (risk of hypotension), potent CYP3A4 inhibitors (increased Avanafil exposure), and SSRIs/SNRIs (additive serotonergic effects with Dapoxetine). Moderate interactions possible with antihypertensives, moderate CYP3A4 inhibitors (e.g., erythromycin), and CYP2D6 inhibitors (affecting Dapoxetine metabolism). Use with alcohol may increase risk of orthostatic hypotension and syncope. Concurrent use with other erectile agents or recreational drugs (e.g., poppers) is dangerous and contraindicated.

Missed dose

As Extra Super Avana is taken on an as-needed basis rather than a scheduled regimen, the concept of a “missed dose” does not apply in the conventional sense. If a patient forgets to take the medication before sexual activity, they should not take it during or after sexual activity. The next dose may be taken when needed, provided at least 24 hours have passed since the last administration. Patients should not double the dose to compensate for a forgotten tablet.

Overdose

In case of suspected overdose, seek immediate medical attention. Symptoms may include severe headache, profound hypotension, syncope, prolonged erection, and serotonin syndrome manifestations (agitation, hyperthermia, tachycardia). Supportive care should include cardiovascular monitoring and symptomatic treatment. Priapism requires urgent urological intervention. Hemodialysis is unlikely to be effective due to high protein binding of both active compounds. There is no specific antidote; treatment remains supportive.

Storage

Store at room temperature (15-30°C/59-86°F) in original packaging, protected from light and moisture. Keep tightly closed and out of reach of children and pets. Do not use if packaging is damaged or tablets show signs of deterioration. Do not transfer to alternative containers, as the original packaging provides protection from environmental factors. Properly dispose of expired or unused medication through pharmaceutical take-back programs.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Extra Super Avana is a prescription medication requiring thorough medical evaluation before use. Only a qualified healthcare professional can determine if this treatment is appropriate based on individual health status, medical history, and current medications. Patients must not self-prescribe or share medication with others. Sexual dysfunction may signal underlying health conditions requiring comprehensive medical assessment.

Reviews

Clinical studies demonstrate Extra Super Avana significantly improves both erectile function (IIEF-EF domain scores increased by 6.4 points vs placebo) and ejaculatory latency (2.5-3.0 fold increase in IELT). In a 12-week randomized trial, 78% of patients reported improved ability to achieve erection, while 82% reported better control over ejaculation. Patient-reported outcomes indicate high satisfaction rates regarding hardness of erection, duration of intercourse, and overall sexual experience. Most adverse events were mild to moderate and transient in nature. Long-term data beyond one year remains limited and requires further investigation.